Nykode Therapeutics AS (OSL: NYKD)
Norway
· Delayed Price · Currency is NOK 6.44
-0.16 (-2.42%)
Aug 30, 2024, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 2.10 billion as of August 30, 2024. Its market cap has decreased by -74.73% in one year.
Market Cap
2.10B
Enterprise Value
699.00M
Revenue
69.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.44
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 2.10B, a decrease of -61.93%. That is a compound annual growth rate of -18.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 30, 2024 | 2.10B | -69.91% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
| Jan 28, 2020 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.02B |
| Nordhealth AS | 2.93B |
| Photocure ASA | 1.51B |
| Carasent ASA | 1.31B |
| ArcticZymes Technologies ASA | 1.01B |
| Hofseth BioCare ASA | 842.72M |
| Gentian Diagnostics ASA | 809.67M |
| Navamedic ASA | 507.29M |